Community care for neovascular age-related macular degeneratio
- Conditions
- eovascular age-related macular degenerationEye DiseasesNeovascular age-related macular degeneration
- Registration Number
- ISRCTN10447645
- Lead Sponsor
- Moorfields Eye Hospital NHS Foundation Trust
- Brief Summary
2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33980536/ (added 18/09/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 707
1. Receiving treatment in nAMD injection clinics
2. Reached agreed definition of disease quiescence
3. Provided informed consent
4. Aged 55 years or older
5. Ability to perform study-specific procedures
1. Significant media opacities (cataracts, vitreous opacities) that do not allow good quality fundus imaging
2. Diabetic retinopathy of severity worse than mild non-proliferative stage and with any degree of diabetic maculopathy
3. History of other causes of choroidal neovascularisation (myopic, angoid streaks, inflammatory, retinal dystrophies, secondary to central serous chorioretinopathy, idiopathic)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method